capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream
RxNorm concept 1422561, clinical drug (scd). Prescribable name: capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % Topical Cream.
- RxCUI
- 1422561
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1422561 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % Topical Cream
Related concepts
- lidocaine 20 MG/ML (SCDC, consists of)
- methyl salicylate 200 MG/ML (SCDC, consists of)
- menthol 50 MG/ML (SCDC, consists of)
- capsaicin 0.35 MG/ML (SCDC, consists of)
- Topical Cream (DF, has dose form)
- capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine] (SBD, has tradename)
- capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Doloracin with Lidocaine] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1422561 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1422561 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1422561. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.